US · Healthcare · Drug Manufacturers - General
EPS came in at 5.15 against a street estimate of 4.77 — a beat of 8.0%.
Analysts rate Amgen Inc a buy (15 buy, 14 hold, 3 sell out of 32) with an average price target of $357.03.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.73% |
| Vanguard Capital Management, LLC | 6.49% |
| State Street Corp | 5.66% |
| Capital World Investors | 5.43% |
| Amvescap Plc. | 2.94% |
| Morgan Stanley - Brokerage Accounts | 2.93% |
| Geode Capital Management, LLC | 2.86% |
| Vanguard Portfolio Management, LLC | 2.71% |
| Document | Date |
|---|---|
| Current report · Q3 2026 | 2026-07-31 |
| Shareholder vote results · Q2 2026 | 2026-05-20 |
| Board / officer change · Q2 2026 | 2026-05-19 |
| Quarterly report · Q1 2026 | 2026-05-01 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-07 |
| Annual report FY2025 | 2026-02-13 |
| Quarterly report · Q3 2025 | 2025-11-05 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $2.52 / share ex-date Aug 21, 2026 · pay Sep 11, 2026 | 2026-08-21 |
| Dividend | $2.52 / share ex-date May 15, 2026 · pay Jun 5, 2026 | 2026-05-15 |
| Dividend | $2.52 / share ex-date Feb 13, 2026 · pay Mar 6, 2026 | 2026-02-13 |
| Dividend | $2.38 / share ex-date Nov 21, 2025 · pay Dec 12, 2025 | 2025-11-21 |
| Dividend | $2.38 / share ex-date Aug 22, 2025 · pay Sep 12, 2025 | 2025-08-22 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Amgen Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.